Publication | Closed Access
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine
76
Citations
32
References
2021
Year
Janssen Vaccines and Infectious Diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1